These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 37422846)
1. Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma. Amin DR; Philips R; Bertoni DG; Mastrolonardo EV; Campbell DJ; Agarwal AM; Tekumalla S; Urdang ZD; Luginbuhl AJ; Cognetti DM; Curry JM JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):980-986. PubMed ID: 37422846 [TBL] [Abstract][Full Text] [Related]
2. Survival and Gastrostomy Prevalence in Patients With Oropharyngeal Cancer Treated With Transoral Robotic Surgery vs Chemoradiotherapy. Sharma A; Patel S; Baik FM; Mathison G; Pierce BH; Khariwala SS; Yueh B; Schwartz SM; Méndez E JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):691-7. PubMed ID: 27347780 [TBL] [Abstract][Full Text] [Related]
3. Survival and Swallowing Function after Primary Radiotherapy versus Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma. Hughes RT; Levine BJ; May N; Shenker RF; Yang JH; Lanier CM; Frizzell BA; Greven KM; Waltonen JD ORL J Otorhinolaryngol Relat Spec; 2023; 85(5):284-293. PubMed ID: 37647863 [TBL] [Abstract][Full Text] [Related]
4. Utilization of Transoral Robotic Surgery (TORS) in patients with Oropharyngeal Squamous Cell Carcinoma and its impact on survival and use of chemotherapy. Baliga S; Kabarriti R; Jiang J; Mehta V; Guha C; Kalnicki S; Smith RV; Garg MK Oral Oncol; 2018 Nov; 86():75-80. PubMed ID: 30409323 [TBL] [Abstract][Full Text] [Related]
5. Outcomes following TORS for HPV-positive oropharyngeal carcinoma: PEGs, tracheostomies, and beyond. Van Abel KM; Quick MH; Graner DE; Lohse CM; Price DL; Price KAR; Ma DJ; Moore EJ Am J Otolaryngol; 2019; 40(5):729-734. PubMed ID: 31303455 [TBL] [Abstract][Full Text] [Related]
6. Association of Transoral Robotic Surgery With Short-term and Long-term Outcomes and Costs of Care in Oropharyngeal Cancer Surgery. Motz K; Chang HY; Quon H; Richmon J; Eisele DW; Gourin CG JAMA Otolaryngol Head Neck Surg; 2017 Jun; 143(6):580-588. PubMed ID: 28358930 [TBL] [Abstract][Full Text] [Related]
7. A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx. Albergotti WG; Jordan J; Anthony K; Abberbock S; Wasserman-Wincko T; Kim S; Ferris RL; Duvvuri U Cancer; 2017 Aug; 123(16):3132-3140. PubMed ID: 28467606 [TBL] [Abstract][Full Text] [Related]
8. Quality of Life After Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharynx Cancer. Silver JA; Bouganim N; Richardson K; Henry M; Mascarella MA; Ramirez-GarciaLuna J; Golabi N; Mlynarek AM; Zeitouni A; Hier MP; Caglar D; Esfahani K; Sadeghi N JAMA Otolaryngol Head Neck Surg; 2024 Jan; 150(1):65-74. PubMed ID: 38060238 [TBL] [Abstract][Full Text] [Related]
9. Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial. Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Odell M; Parker C; Wehrli B; Kwan K; Palma DA J Clin Oncol; 2022 Mar; 40(8):866-875. PubMed ID: 34995124 [TBL] [Abstract][Full Text] [Related]
10. Treatment outcomes of transoral robotic and non-robotic surgeries to treat oropharyngeal, hypopharyngeal, and supraglottic squamous cell carcinoma: A multi-center retrospective observational study in Japan. Sano D; Shimizu A; Tateya I; Fujiwara K; Mori T; Miyamoto S; Nishikawa D; Terada T; Yasumatsu R; Ueda T; Matsumoto F; Kishimoto Y; Maruo T; Fujimoto Y; Tsukahara K; Yoshimoto S; Nibu KI; Oridate N Auris Nasus Larynx; 2021 Jun; 48(3):502-510. PubMed ID: 33632582 [TBL] [Abstract][Full Text] [Related]
11. Long-term Functional and Quality-of-Life Outcomes After Transoral Robotic Surgery in Patients With Oropharyngeal Cancer. Achim V; Bolognone RK; Palmer AD; Graville DJ; Light TJ; Li R; Gross N; Andersen PE; Clayburgh D JAMA Otolaryngol Head Neck Surg; 2018 Jan; 144(1):18-27. PubMed ID: 29075740 [TBL] [Abstract][Full Text] [Related]
12. Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation. Ling DC; Chapman BV; Kim J; Choby GW; Kabolizadeh P; Clump DA; Ferris RL; Kim S; Beriwal S; Heron DE; Duvvuri U Oral Oncol; 2016 Oct; 61():41-6. PubMed ID: 27688103 [TBL] [Abstract][Full Text] [Related]
13. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial. Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Eapen L; Odell M; Parker C; Wehrli B; Kwan K; Palma DA Lancet Oncol; 2019 Oct; 20(10):1349-1359. PubMed ID: 31416685 [TBL] [Abstract][Full Text] [Related]
14. Optimized decision support for selection of transoral robotic surgery or (chemo)radiation therapy based on posttreatment swallowing toxicity. Hemmati M; Barbon C; Mohamed ASR; van Dijk LV; Moreno AC; Gross ND; Goepfert RP; Lai SY; Hutcheson KA; Schaefer AJ; Fuller CD; Cancer Med; 2023 Feb; 12(4):5088-5098. PubMed ID: 36229990 [TBL] [Abstract][Full Text] [Related]
15. Treatment of oropharyngeal squamous cell carcinoma: Is swallowing quality better after TORS or RT? Campo F; Iocca O; De Virgilio A; Mazzola F; Mercante G; Pichi B; Holsinger FC; Di Maio P; Ramella S; Pellini R Radiother Oncol; 2023 Jun; 183():109547. PubMed ID: 36813176 [TBL] [Abstract][Full Text] [Related]
16. National Trends in 30-Day Readmission Following Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma. Nyirjesy SC; McCrary HC; Zhao S; Judd RT; Farlow JL; Seim NB; Ozer E; Agrawal A; Old MO; Rocco JW; Kang SY; Haring CT JAMA Otolaryngol Head Neck Surg; 2024 Feb; 150(2):133-141. PubMed ID: 38153724 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for gastrostomy tube dependence in transoral robotic surgery patients. Philips R; Topf MC; Vimawala S; Luginbuhl A; Curry JM; Cognetti DM Am J Otolaryngol; 2022; 43(1):103175. PubMed ID: 34418824 [TBL] [Abstract][Full Text] [Related]
18. Quality of life outcomes of transoral robotic surgery with or without adjuvant therapy for oropharyngeal cancer. Sethia R; Yumusakhuylu AC; Ozbay I; Diavolitsis V; Brown NV; Zhao S; Wei L; Old M; Agrawal A; Teknos TN; Ozer E Laryngoscope; 2018 Feb; 128(2):403-411. PubMed ID: 28771728 [TBL] [Abstract][Full Text] [Related]
19. Outcomes of transoral laser microsurgery and transoral robotic surgery in oropharyngeal squamous cell carcinoma. Sievert M; Goncalves M; Zbidat A; Traxdorf M; Mueller SK; Iro H; Gostian AO Auris Nasus Larynx; 2021 Apr; 48(2):295-301. PubMed ID: 32883577 [TBL] [Abstract][Full Text] [Related]
20. Obesity and Survival After Immune Checkpoint Inhibition for Head and Neck Squamous Cell Carcinoma. Mastrolonardo EV; Llerena P; Lu J; Nunes K; Choi GK; Amin D; Bridgham KM; Campbell D; Philips R; Cognetti DM; Luginbuhl AJ; Curry JM JAMA Otolaryngol Head Neck Surg; 2024 Aug; 150(8):688-694. PubMed ID: 38958948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]